Matthew S. Waitkus

1.5k total citations
25 papers, 776 citations indexed

About

Matthew S. Waitkus is a scholar working on Molecular Biology, Cancer Research and Genetics. According to data from OpenAlex, Matthew S. Waitkus has authored 25 papers receiving a total of 776 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 11 papers in Cancer Research and 9 papers in Genetics. Recurrent topics in Matthew S. Waitkus's work include Glioma Diagnosis and Treatment (9 papers), DNA Repair Mechanisms (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Matthew S. Waitkus is often cited by papers focused on Glioma Diagnosis and Treatment (9 papers), DNA Repair Mechanisms (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Matthew S. Waitkus collaborates with scholars based in United States, China and Canada. Matthew S. Waitkus's co-authors include Hai Yan, Bill H. Diplas, Paul E. DiCorleto, Christopher J. Pirozzi, Landon J. Hansen, Unni M. Chandrasekharan, Roger E. McLendon, Darell D. Bigner, Lee H. Chen and Paula K. Greer and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Molecular and Cellular Biology.

In The Last Decade

Matthew S. Waitkus

23 papers receiving 773 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew S. Waitkus United States 13 429 337 287 133 87 25 776
Christopher J. Pirozzi United States 12 374 0.9× 255 0.8× 246 0.9× 101 0.8× 70 0.8× 25 689
Alexandra Borodovsky United States 14 698 1.6× 312 0.9× 229 0.8× 220 1.7× 111 1.3× 26 1.0k
Ling-Ling Gong China 7 598 1.4× 433 1.3× 594 2.1× 123 0.9× 75 0.9× 10 1.1k
Ingrid Moen Norway 8 393 0.9× 263 0.8× 415 1.4× 187 1.4× 76 0.9× 16 934
Bill H. Diplas United States 14 603 1.4× 401 1.2× 369 1.3× 135 1.0× 71 0.8× 27 1.2k
I‐Mei Siu United States 16 494 1.2× 292 0.9× 190 0.7× 160 1.2× 71 0.8× 22 823
John F. de Groot United States 11 384 0.9× 417 1.2× 238 0.8× 218 1.6× 175 2.0× 14 856
Caroline Delmas France 22 794 1.9× 343 1.0× 433 1.5× 408 3.1× 139 1.6× 37 1.4k
Mirjam Hermisson Germany 14 614 1.4× 504 1.5× 232 0.8× 229 1.7× 108 1.2× 17 1.1k
Michael De Lay United States 8 546 1.3× 224 0.7× 387 1.3× 206 1.5× 171 2.0× 10 900

Countries citing papers authored by Matthew S. Waitkus

Since Specialization
Citations

This map shows the geographic impact of Matthew S. Waitkus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew S. Waitkus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew S. Waitkus more than expected).

Fields of papers citing papers by Matthew S. Waitkus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew S. Waitkus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew S. Waitkus. The network helps show where Matthew S. Waitkus may publish in the future.

Co-authorship network of co-authors of Matthew S. Waitkus

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew S. Waitkus. A scholar is included among the top collaborators of Matthew S. Waitkus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew S. Waitkus. Matthew S. Waitkus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pirozzi, Christopher J., Bill H. Diplas, Roger E. McLendon, et al.. (2026). SMARCAL1 is a targetable synthetic lethal therapeutic vulnerability in ATRX-deficient gliomas that use alternative lengthening of telomeres. Neuro-Oncology.
2.
Wisdom, Amy J., Lixia Luo, Yan Ma, et al.. (2025). Loss of function of Atrx recapitulates phenotypes of alternative lengthening of telomeres in a primary mouse model of sarcoma. iScience. 28(5). 112357–112357. 1 indexed citations
3.
Low, Justin, Michael C. Brown, Zachary J. Reitman, et al.. (2024). Understanding and therapeutically exploiting cGAS/STING signaling in glioblastoma. Journal of Clinical Investigation. 134(2). 29 indexed citations
4.
Liu, Heng, Cheng Xu, Bill H. Diplas, et al.. (2023). Cancer-associated SMARCAL1 loss-of-function mutations promote alternative lengthening of telomeres and tumorigenesis in telomerase-negative glioblastoma cells. Neuro-Oncology. 25(9). 1563–1575. 11 indexed citations
5.
Diplas, Bill H., et al.. (2023). Abstract 3143: A bioinformatic pipeline for identifying change-of-metabolic-function cancer mutations. Cancer Research. 83(7_Supplement). 3143–3143. 1 indexed citations
6.
Hendrickson, Peter G., Joshua A. Regal, So Young Kim, et al.. (2023). Pooled genetic screens to identify vulnerabilities in TERT-promoter-mutant glioblastoma. Oncogene. 42(44). 3274–3286. 3 indexed citations
7.
Diplas, Bill H., et al.. (2023). Mining cancer genomes for change-of-metabolic-function mutations. Communications Biology. 6(1). 1143–1143.
8.
Xu, Cheng, Heng Liu, Christopher J. Pirozzi, et al.. (2021). TP53 wild-type/PPM1D mutant diffuse intrinsic pontine gliomas are sensitive to a MDM2 antagonist. Acta Neuropathologica Communications. 9(1). 178–178. 12 indexed citations
9.
Wang, Zhaohui, Cheng Xu, Bill H. Diplas, et al.. (2020). Targeting Mutant PPM1D Sensitizes Diffuse Intrinsic Pontine Glioma Cells to the PARP Inhibitor Olaparib. Molecular Cancer Research. 18(7). 968–980. 19 indexed citations
10.
Waitkus, Matthew S. & Hai Yan. (2020). Targeting Isocitrate Dehydrogenase Mutations in Cancer: Emerging Evidence and Diverging Strategies. Clinical Cancer Research. 27(2). 383–388. 14 indexed citations
11.
Moure, Casey J., Bill H. Diplas, Lee H. Chen, et al.. (2019). CRISPR Editing of Mutant IDH1 R132H Induces a CpG Methylation-Low State in Patient-Derived Glioma Models of G-CIMP. Molecular Cancer Research. 17(10). 2042–2050. 17 indexed citations
12.
Liu, Yang, Austin B. Carpenter, Christopher J. Pirozzi, et al.. (2019). Non-invasive sensitive brain tumor detection using dual-modality bioimaging nanoprobe. Nanotechnology. 30(27). 275101–275101. 19 indexed citations
13.
Baig, Shahid Mahmood, Ambrin Fatima, Muhammad Tariq, et al.. (2018). Hereditary brain tumor with a homozygous germline mutation in PMS2: pedigree analysis and prenatal screening in a family with constitutional mismatch repair deficiency (CMMRD) syndrome. Familial Cancer. 18(2). 261–265. 2 indexed citations
14.
Yang, Rui, Lee H. Chen, Landon J. Hansen, et al.. (2017). Cic Loss Promotes Gliomagenesis via Aberrant Neural Stem Cell Proliferation and Differentiation. Cancer Research. 77(22). 6097–6108. 33 indexed citations
15.
Pirozzi, Christopher J., Austin B. Carpenter, Matthew S. Waitkus, et al.. (2017). Mutant IDH1 Disrupts the Mouse Subventricular Zone and Alters Brain Tumor Progression. Molecular Cancer Research. 15(5). 507–520. 31 indexed citations
16.
Waitkus, Matthew S., Christopher J. Pirozzi, Casey J. Moure, et al.. (2017). Adaptive Evolution of the GDH2 Allosteric Domain Promotes Gliomagenesis by Resolving IDH1R132H-Induced Metabolic Liabilities. Cancer Research. 78(1). 36–50. 33 indexed citations
17.
Waitkus, Matthew S., Bill H. Diplas, & Hai Yan. (2015). Isocitrate dehydrogenase mutations in gliomas. Neuro-Oncology. 18(1). 16–26. 215 indexed citations
18.
Waitkus, Matthew S., Unni M. Chandrasekharan, Belinda Willard, et al.. (2014). Signal Integration and Gene Induction by a Functionally Distinct STAT3 Phosphoform. Molecular and Cellular Biology. 34(10). 1800–1811. 36 indexed citations
19.
Waitkus, Matthew S., Unni M. Chandrasekharan, Belinda Willard, S. Jaharul Haque, & Paul E. DiCorleto. (2013). STAT3-mediated Coincidence Detection Regulates Noncanonical Immediate Early Gene Induction. Journal of Biological Chemistry. 288(17). 11988–12003. 9 indexed citations
20.
Chandrasekharan, Unni M., et al.. (2010). Synergistic Induction of Mitogen-Activated Protein Kinase Phosphatase-1 by Thrombin and Epidermal Growth Factor Requires Vascular Endothelial Growth Factor Receptor-2. Arteriosclerosis Thrombosis and Vascular Biology. 30(10). 1983–1989. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christopher J. Pirozzi Breakdown of academic impact, for papers by Alexandra Borodovsky Breakdown of academic impact, for papers by Ling-Ling Gong Breakdown of academic impact, for papers by Ingrid Moen Breakdown of academic impact, for papers by Bill H. Diplas Breakdown of academic impact, for papers by I‐Mei Siu Breakdown of academic impact, for papers by John F. de Groot Breakdown of academic impact, for papers by Caroline Delmas Breakdown of academic impact, for papers by Mirjam Hermisson Breakdown of academic impact, for papers by Michael De Lay
Rankless by CCL
2026